» Articles » PMID: 24860551

Neuropsychiatric Comorbidity in Obesity: Role of Inflammatory Processes

Overview
Specialty Endocrinology
Date 2014 May 27
PMID 24860551
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropsychiatric symptoms are frequent in obesity. In addition to their substantial economic and health impact, these symptoms significantly interfere with the quality of life and social function of obese individuals. While the pathophysiological mechanisms underlying obesity-related neuropsychiatric symptoms are still under investigation and remain to be clearly identified, there is increasing evidence for a role of inflammatory processes. Obesity is characterized by a chronic low-grade inflammatory state that is likely to influence neuropsychiatric status given the well-known and highly documented effects of inflammation on brain activity/function and behavior. This hypothesis is supported by recent findings emanating from clinical investigations in obese subjects and from experimentations conducted in animal models of obesity. These studies converge to show that obesity-related inflammatory processes, originating either from the adipose tissue or gut microbiota environment, spread to the brain where they lead to substantial changes in neurocircuitry, neuroendocrine activity, neurotransmitter metabolism and activity, and neurogenesis. Together, these alterations contribute to shape the propitious bases for the development of obesity-related neuropsychiatric comorbidities.

Citing Articles

High-fat diet, microbiome-gut-brain axis signaling, and anxiety-like behavior in male rats.

de Noronha S, de Moraes L, Hassell Jr J, Stamper C, Arnold M, Heinze J Biol Res. 2024; 57(1):23.

PMID: 38705984 PMC: 11071217. DOI: 10.1186/s40659-024-00505-1.


Human gut microbiome, diet, and mental disorders.

Borrego-Ruiz A, Borrego J Int Microbiol. 2024; 28(1):1-15.

PMID: 38561477 PMC: 11775079. DOI: 10.1007/s10123-024-00518-6.


E-Cigarette Exposure Alters Neuroinflammation Gene and Protein Expression in a Murine Model: Insights from Perinatally Exposed Offspring and Post-Birth Mothers.

Awada C, Saporito A, Zelikoff J, Klein C Genes (Basel). 2024; 15(3).

PMID: 38540381 PMC: 10970539. DOI: 10.3390/genes15030322.


Association between increased BMI and cognitive function in first-episode drug-naïve male schizophrenia.

Deng X, Lu S, Li Y, Fang X, Zhang R, Shen X Front Psychiatry. 2024; 15:1362674.

PMID: 38505798 PMC: 10948420. DOI: 10.3389/fpsyt.2024.1362674.


Depressive Symptoms are Associated With C-Reactive Protein in Older Adults With Obesity.

Heisey H, Qualls C, Villareal D, Segoviano-Escobar M, Nava M, Gatchel J J Geriatr Psychiatry Neurol. 2023; 37(4):332-338.

PMID: 37950647 PMC: 11087374. DOI: 10.1177/08919887231215041.


References
1.
Roberts R, Geda Y, Knopman D, Cha R, Boeve B, Ivnik R . Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord. 2009; 24(1):11-8. PMC: 2837096. DOI: 10.1097/WAD.0b013e3181a4485c. View

2.
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R . Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003; 289(14):1799-804. DOI: 10.1001/jama.289.14.1799. View

3.
Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante Jr A . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808. PMC: 296995. DOI: 10.1172/JCI19246. View

4.
Yates K, Sweat V, Yau P, Turchiano M, Convit A . Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol. 2012; 32(9):2060-7. PMC: 3442257. DOI: 10.1161/ATVBAHA.112.252759. View

5.
Elias M, Elias P, Sullivan L, Wolf P, DAgostino R . Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003; 27(2):260-8. DOI: 10.1038/sj.ijo.802225. View